Us Physical Therapy Inc (USPH)

$97.49

-0.63

(-0.64%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Us Physical Therapy Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 150.00M → 154.80M (in $), with an average increase of 3.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 11.42M → -5.73M (in $), with an average decrease of 74.7% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 57.2%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 12.8% return, outperforming this stock by 23.6%

Performance

  • $97.41
    $98.38
    $97.49
    downward going graph

    0.09%

    Downside

    Day's Volatility :0.99%

    Upside

    0.91%

    downward going graph
  • $77.37
    $122.46
    $97.49
    downward going graph

    20.64%

    Downside

    52 Weeks Volatility :36.82%

    Upside

    20.39%

    downward going graph

Returns

PeriodUs Physical Therapy IncSector (Health Care)Index (Russel 2000)
3 Months
4.56%
-0.7%
0.0%
6 Months
11.25%
6.6%
0.0%
1 Year
-4.29%
3.7%
-1.5%
3 Years
-11.0%
14.0%
-21.8%

Highlights

Market Capitalization
1.5B
Book Value
$31.77
Dividend Share
1.72
Dividend Yield
1.77%
Earnings Per Share (EPS)
1.28
PE Ratio
77.52
PEG Ratio
6.94
Wall Street Target Price
119.88
Profit Margin
4.72%
Operating Margin TTM
10.84%
Return On Assets TTM
4.69%
Return On Equity TTM
6.55%
Revenue TTM
598.6M
Revenue Per Share TTM
42.19
Quarterly Revenue Growth YOY
9.6%
Gross Profit TTM
112.0M
EBITDA
85.3M
Diluted Eps TTM
1.28
Quarterly Earnings Growth YOY
-0.3
EPS Estimate Current Year
2.77
EPS Estimate Next Year
3.09
EPS Estimate Current Quarter
0.57
EPS Estimate Next Quarter
0.65

Analyst Recommendation

Buy
    83%Buy
    16%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Us Physical Therapy Inc(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
8
Hold
2
2
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 22.97%

Current $97.49
Target $119.88

Company Financials

FY18Y/Y Change
Revenue
453.9M
↑ 9.63%
Net Income
10.1M
↓ 54.61%
Net Profit Margin
2.23%
↓ 3.15%
FY19Y/Y Change
Revenue
482.0M
↑ 6.18%
Net Income
57.3M
↑ 466.75%
Net Profit Margin
11.88%
↑ 9.65%
FY20Y/Y Change
Revenue
423.0M
↓ 12.24%
Net Income
52.5M
↓ 8.33%
Net Profit Margin
12.41%
↑ 0.53%
FY21Y/Y Change
Revenue
495.0M
↑ 17.04%
Net Income
57.9M
↑ 10.35%
Net Profit Margin
11.7%
↓ 0.71%
FY22Y/Y Change
Revenue
553.1M
↑ 11.74%
Net Income
43.4M
↓ 25.06%
Net Profit Margin
7.85%
↓ 3.85%
FY23Y/Y Change
Revenue
604.8M
↑ 9.34%
Net Income
14.7M
↓ 66.19%
Net Profit Margin
2.43%
↓ 5.42%
Q3 FY22Q/Q Change
Revenue
139.6M
↓ 0.75%
Net Income
12.8M
↓ 15.96%
Net Profit Margin
9.18%
↓ 1.67%
Q4 FY22Q/Q Change
Revenue
141.2M
↑ 1.13%
Net Income
2.6M
↓ 79.67%
Net Profit Margin
1.85%
↓ 7.33%
Q1 FY23Q/Q Change
Revenue
148.5M
↑ 5.19%
Net Income
11.4M
↑ 338.32%
Net Profit Margin
7.69%
↑ 5.84%
Q2 FY23Q/Q Change
Revenue
151.5M
↑ 2.0%
Net Income
8.1M
↓ 29.52%
Net Profit Margin
5.32%
↓ 2.37%
Q3 FY23Q/Q Change
Revenue
150.0M
↓ 0.98%
Net Income
7.0M
↓ 12.94%
Net Profit Margin
4.67%
↓ 0.65%
Q4 FY23Q/Q Change
Revenue
154.8M
↑ 3.2%
Net Income
-5.7M
↓ 181.72%
Net Profit Margin
-3.7%
↓ 8.37%
FY18Y/Y Change
Total Assets
443.2M
↑ 5.77%
Total Liabilities
92.3M
↓ 16.06%
FY19Y/Y Change
Total Assets
560.8M
↑ 26.55%
Total Liabilities
181.4M
↑ 96.42%
FY20Y/Y Change
Total Assets
594.4M
↑ 5.98%
Total Liabilities
184.4M
↑ 1.65%
FY21Y/Y Change
Total Assets
749.4M
↑ 26.09%
Total Liabilities
297.0M
↑ 61.06%
FY22Y/Y Change
Total Assets
858.2M
↑ 14.51%
Total Liabilities
373.6M
↑ 25.79%
FY23Y/Y Change
Total Assets
1.0B
↑ 19.8%
Total Liabilities
375.8M
↑ 0.6%
Q3 FY22Q/Q Change
Total Assets
799.7M
↑ 0.41%
Total Liabilities
332.9M
↓ 0.94%
Q4 FY22Q/Q Change
Total Assets
858.2M
↑ 7.31%
Total Liabilities
373.6M
↑ 12.21%
Q1 FY23Q/Q Change
Total Assets
868.1M
↑ 1.16%
Total Liabilities
384.4M
↑ 2.89%
Q2 FY23Q/Q Change
Total Assets
999.6M
↑ 15.14%
Total Liabilities
344.1M
↓ 10.48%
Q3 FY23Q/Q Change
Total Assets
1.0B
↑ 1.06%
Total Liabilities
342.0M
↓ 0.61%
Q4 FY23Q/Q Change
Total Assets
1.0B
↑ 1.77%
Total Liabilities
375.8M
↑ 9.9%
FY18Y/Y Change
Operating Cash Flow
73.0M
↑ 29.15%
Investing Cash Flow
-23.9M
↓ 45.13%
Financing Cash Flow
-47.7M
↑ 330.74%
FY19Y/Y Change
Operating Cash Flow
62.4M
↓ 14.46%
Investing Cash Flow
-38.0M
↑ 58.91%
Financing Cash Flow
-24.3M
↓ 49.07%
FY20Y/Y Change
Operating Cash Flow
100.0M
↑ 60.13%
Investing Cash Flow
-51.2M
↑ 34.77%
Financing Cash Flow
-39.4M
↑ 62.4%
FY21Y/Y Change
Operating Cash Flow
76.4M
↓ 23.59%
Investing Cash Flow
-124.1M
↑ 142.44%
Financing Cash Flow
43.4M
↓ 210.04%
FY22Y/Y Change
Operating Cash Flow
58.5M
↓ 23.39%
Investing Cash Flow
-81.3M
↓ 34.53%
Financing Cash Flow
25.8M
↓ 40.62%
Q3 FY22Q/Q Change
Operating Cash Flow
13.7M
↓ 13.46%
Investing Cash Flow
-14.3M
↑ 88.76%
Financing Cash Flow
-10.0M
↓ 162.49%
Q4 FY22Q/Q Change
Operating Cash Flow
17.3M
↑ 26.02%
Investing Cash Flow
-43.4M
↑ 202.63%
Financing Cash Flow
19.8M
↓ 296.8%
Q1 FY23Q/Q Change
Operating Cash Flow
11.3M
↓ 34.4%
Investing Cash Flow
-12.7M
↓ 70.78%
Financing Cash Flow
2.3M
↓ 88.15%
Q2 FY23Q/Q Change
Operating Cash Flow
27.4M
↑ 141.7%
Investing Cash Flow
-7.0M
↓ 44.96%
Financing Cash Flow
107.7M
↑ 4495.9%
Q3 FY23Q/Q Change
Operating Cash Flow
16.4M
↓ 40.34%
Investing Cash Flow
-16.9M
↑ 142.74%
Financing Cash Flow
-12.5M
↓ 111.59%

Technicals Summary

Sell

Neutral

Buy

Us Physical Therapy Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Us Physical Therapy Inc
Us Physical Therapy Inc
-8.27%
11.25%
-4.29%
-11.0%
-10.77%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-0.32%
10.42%
-15.35%
-50.85%
-51.82%
Hca Holdings, Inc.
Hca Holdings, Inc.
-4.93%
28.25%
14.58%
59.59%
169.9%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-4.36%
72.26%
44.71%
82.68%
310.08%
Universal Health Services Inc.
Universal Health Services Inc.
-9.74%
24.99%
16.98%
9.58%
28.53%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-6.85%
62.1%
52.88%
15.22%
144.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Us Physical Therapy Inc
Us Physical Therapy Inc
77.52
77.52
6.94
2.77
0.07
0.05
0.02
31.77
Fresenius Medical Care Ag
Fresenius Medical Care Ag
20.44
20.44
0.39
2.04
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
17.0
17.0
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.21
17.21
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.27
16.27
1.87
13.45
0.12
0.05
0.0
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.49
17.49
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Us Physical Therapy Inc
Us Physical Therapy Inc
Buy
$1.5B
-10.77%
77.52
4.72%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$10.9B
-51.82%
20.44
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$85.3B
169.9%
17.0
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
310.08%
17.21
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.2B
28.53%
16.27
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.3B
144.38%
17.49
5.7%

Institutional Holdings

  • BlackRock Inc

    15.38%

  • Kayne Anderson Rudnick Investment Management LLC

    9.06%

  • Morgan Stanley - Brokerage Accounts

    7.41%

  • Vanguard Group Inc

    7.05%

  • T. Rowe Price Investment Management,Inc.

    5.05%

  • Copeland Capital Management, LLC

    4.96%

Corporate Announcements

  • Us Physical Therapy Inc Dividends March,2023

    In the quarter ending March,2023. Us Physical Therapy Inc has declared dividend of $0.43

    Read More

Company Information

u.s. physical therapy is a publicly held company that operates hundreds of outpatient physical and occupational therapy clinics in over 40 states. the company's clinics provide acute, post-operative, and preventative care for a variety of orthopedic and neurologic disorders including sports and work related injuries. the unique nature of the company is its operating structure - the company's clinics are developed and operated through partnerships with therapists who share in the clinic's profits. in addition to the therapist partnership model, u.s. physical therapy also buys into existing physical therapy practices.

Organization
Us Physical Therapy Inc
Employees
3899
CEO
Mr. Christopher J. Reading
Industry
Health Services

Discover More

FAQs